RICT 2016

Online registration is still open! REGISTER NOW!

Media Partner

Conferences > Archives > RICT 2016

Confirmed Speakers


Plenary Speakers

Prof. Jean-Daniel BRION
Prof. Jean-Daniel BRION
UNIVERSITÉ PARIS-SUD, Chatenay-Malabry, France
Read more

Paul Ehrlich Prize Lecture
Trip in Drug Discovery (PL01)

Dr Alan BROWN
Dr Alan BROWN
STRATIFIED MEDICAL, London, United Kingdom
Read more

The Discovery and Optimization of Benzimidzoles as Selective NAV1.8 Blockers for the Treatment of Pain (PL06)

Dr Pascal FURET
Dr Pascal FURET
NOVARTIS, Basel, Switzerland
Read more

Conquering the p53-MDM2 Protein-Protein Interaction Target at Novartis (PL21)

Dr Mike HANN
Dr Mike HANN
GLAXOSMITHKLINE, Stevenage, United Kingdom
Read more

Towards an Understanding of Cellular Drug Efficiency as a Way to Control Molecular Obesity (PL20)

Dr Michael HENNIG
Dr Michael HENNIG
LEADXPRO AG, Villigen, Switzerland
Read more

Advances in Structure Based Drug Discovery of Membrane Protein Targets (PL14)

Dr James R. HENRY
Dr James R. HENRY
ELI LILLY & CO., Indianapolis, United States
Read more

Discovery of the Type II Kinase Inhibitor LY3009120; a Pan-RAF Inhibitor Showing Minimal Paradoxical Activation and Anti-Cancer Activity Against BRAF or RAS Mutant Tumor Cells (PL22)

Dr Jan HOFLACK
Dr Jan HOFLACK
ONCODESIGN, Dijon, France
Read more

Nanocyclix: a Chemical Biology Approach for Next Generation Kinase Inhibitors (PL08)

Dr Eva JAKAB-TOTH
Dr Eva JAKAB-TOTH
CNRS, Orléans, France
Read more

Molecular Imaging Agents Based on Lanthanide Complexes (PL17)

Dr Sven KÜHNERT
Dr Sven KÜHNERT
GRUENENTHAL GMBH, Aachen, Germany
Read more

Optimization and Exploration of Bradykinin 1 Receptor Antagonists for Inflammation (PL07)

Prof. Bernhard KÜSTER
Prof. Bernhard KÜSTER
TECHNICAL UNIVERSITY MUNICH, Munich, Germany
Read more

Human Proteomes – from Basic Biology to Understanding Drug Action (PL02)

Dr Oleg MELNYK
Dr Oleg MELNYK
CNRS / UNIVERSITY OF LILLE / PASTEUR INSTITUTE OF LILLE, Lille, France
Read more

Protein Total Synthesis and the Challenge of Understanding MET Tyrosine Kinase Receptor Activation (PL11)

Prof. Adam NELSON
Prof. Adam NELSON
UNIVERSITY OF LEEDS, Leeds, United Kingdom
Read more

The Realisation of Activity-Directed Synthesis (PL19)

Dr Jean-Claude ORTUNO
Dr Jean-Claude ORTUNO
INSTITUT DE RECHERCHES SERVIER, SURESNES, France
Read more

Discovery of Selective Dopaminergic D3 Receptor Antagonists with Potent 5HT6 Affinity (PL10)

Dr Jean-Philippe PIN
Dr Jean-Philippe PIN
CNRS / INSERM / UNIVERSITY OF MONTPELLIER, Montpellier, France
Read more

Innovative Approaches to Control Metabotropic Glutamate Receptor Activity in the Brain (PL15)

Dr Santiago RIVERA
Dr Santiago RIVERA
CNRS / AIX-MARSEILLE UNIVERSITY, Marseille, France
Read more

MT5-MMP, a New Potential Therapeutic Target in Alzheimer’s Disease (PL09)

Prof. Young-Ger SUH
Prof. Young-Ger SUH
SEOUL NATIONAL UNIVERSITY, Seoul, Korea, South
Read more

Development of Novel Antiangiogenic Agents for the Treatment of Retinal Neovascularization via Integration of Chemistry and Biology (PL12)

Prof. Edward TATE
Prof. Edward TATE
IMPERIAL COLLEGE LONDON, London, United Kingdom
Read more

Protein Modification: from Chemical Biology to Drug Discovery (PL04)

Prof. Yasuteru URANO
Prof. Yasuteru URANO
THE UNIVERSITY OF TOKYO, Tokyo, Japan
Read more

Novel Fluorogenic Probes for In Vivo Imaging of Tiny Tumors and Super-Resolution Imaging in Living Cells (PL18)

Dr Michiel VAN GOOL
Dr Michiel VAN GOOL
JANSSEN R&D, Toledo, Spain
Read more

The Design of mGluR Modulators for CNS Disorders (PL16)

Dr Bruno VILLOUTREIX
Dr Bruno VILLOUTREIX
INSERM / UNIVERSITY PARIS DIDEROT, Paris, France
Read more

Design of Chemical Probes Acting on Emerging Targets Assisted by Online Computational Tools (PL13)

Dr Alain WAGNER
Dr Alain WAGNER
CNRS / UNIVERSITY OF STRASBOURG, Illkirch, France

Read more

Pierre Fabre Award for Therapeutic Innovation
A Scien-trepreneur Journey From Digital to In-vivo Organic Chemistry (PL23)

Dr Minoru YOSHIDA
Dr Minoru YOSHIDA
RIKEN ADVANCED SCIENCE INSTITUTE (ASI), Saitama, Japan
Read more

A Role of SIRT2 in Cellular Response to Environmental Signals (PL05)

Dr Andrew ZHANG
Dr Andrew ZHANG
ASTRAZENECA R&D, Waltham, United States
Read more

Target Deconvolution Efforts Around Wnt Pathway Screen Reveal Parallel Mechanisms of Action for 1,2,3-Thiadiazole-5-Carboxamide Series (PL03)

Keynote Speakers

Dr Céline CANO
Dr Céline CANO
NEWCASTLE CANCER CENTRE, Newcastle upon Tyne, United Kingdom
Read more

Development of Potent Inhibitors of the DNA-Dependent Protein Kinase (DNA-PK) (KL03)

Dr Sylvie CLAEYSEN
Dr Sylvie CLAEYSEN
INSTITUT DE GÉNOMIQUE FONCTIONNELLE / CNRS / INSERM, Montpellier , France
Read more

Original Serotonergic Multi-Target Directed Ligands against Alzheimer's Disease (KL02)

Dr Nicolas DESROY
Dr Nicolas DESROY
GALAPAGOS, Romainville, France

Discovery of GLPG1690: a First-in-Class Autotaxin Inhibitor in Clinical Development for the Treatment of Idiopathic Pulmonary Fibrosis ( KL01)

Dr Steven DURRANT
Dr Steven DURRANT
VERTEX PHARMACEUTICALS (EUROPE) LTD, Abingdon, United Kingdom
Read more

Fragment-Based Design of ITK Inhibitors (KL06)

Dr Sébastien GOUIN
Dr Sébastien GOUIN
CNRS / UNIVERSITY OF NANTES, Nantes, France
Read more

E.coli Anti-Adhesives, Potential Therapeutics for Crohn's Disease? (KL08)

Dr András KOTSCHY
Dr András KOTSCHY
SERVIER RESEARCH INSTITUTE OF MEDICINAL CHEMISTRY, Budapest, Hungary
Read more

Structure Guided Drug Discovery: Merits and Pitfalls Through the Example of Two Kinase Projects (KL04)

Dr Isabelle KRIMM
Dr Isabelle KRIMM
CNRS / UNIVERSITY OF LYON 1, Villeurbanne, France
Read more

NMR for Chemical Biology and Drug Discovery (KL05)

Dr Françoise OCHSENBEIN
Dr Françoise OCHSENBEIN
CEA SACLAY, Gif-sur-Yvette, France
Read more

Inhibiting Chromatin Assembly by Targeting Histone Chaperones (KL07)


Organised by

EFMC Sponsored Event

Premium Exhibitor

Sponsors

Media Partners

Copyright 2017 LD Organisation  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 10 454777  |   |  VAT: BE 0464819842
Developed and powered by Antalys